VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 127 filers reported holding VAXCYTE INC in Q3 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,403,651 | -0.5% | 380,613 | -2.5% | 0.23% | -1.7% |
Q2 2023 | $19,499,373 | +108.1% | 390,456 | +56.2% | 0.23% | +81.9% |
Q1 2023 | $9,370,000 | -21.8% | 250,000 | 0.0% | 0.13% | -20.6% |
Q4 2022 | $11,987,500 | +154.3% | 250,000 | +27.3% | 0.16% | +142.4% |
Q3 2022 | $4,714,000 | -53.5% | 196,429 | -57.9% | 0.07% | -57.7% |
Q2 2022 | $10,147,000 | +337.9% | 466,324 | +378.8% | 0.16% | +372.7% |
Q4 2021 | $2,317,000 | +218.3% | 97,396 | +323.0% | 0.03% | +13.8% |
Q2 2020 | $728,000 | – | 23,026 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 4,168,718 | $100,049,000 | 34.21% |
Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $45,299,000 | 18.86% |
Pivotal bioVenture Partners Investment Advisor LLC | 776,039 | $18,625,000 | 6.81% |
Kynam Capital Management, LP | 698,638 | $16,767,000 | 3.53% |
GREAT POINT PARTNERS LLC | 600,000 | $14,400,000 | 3.47% |
Frazier Life Sciences Management, L.P. | 1,547,405 | $37,138,000 | 2.86% |
Ghost Tree Capital, LLC | 360,000 | $8,640,000 | 2.42% |
RA Capital Management | 4,581,203 | $109,949,000 | 2.35% |
Opaleye Management Inc. | 190,000 | $4,560,000 | 1.88% |
TPG GP A, LLC | 3,285,504 | $78,852,000 | 1.29% |